Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $7.78 -0.11 (-1.39%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.73Holdings in PILL have an aggregate rating of Moderate Buy based on 374 analyst ratings issued in the past year covering 44 companies (73.5% of the portfolio).PILL Aggregate Price Target$7.78High Prediction$7.78Average Prediction$7.78Low Prediction$7.78Holdings in PILL have an aggregate price target of $7.78 and a range of $7.78 to $7.78 covering 44 companies (73.5% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.97%ITCIIntra-Cellular Therapies$128.60+0.0%3.8866 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage3.36%AXSMAxsome Therapeutics$137.75+6.7%4.5296 of 5 stars3.00$157.64 14.4%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.35%RPRXRoyalty Pharma$33.42+0.3%4.5708 of 5 stars3.00$41.60 24.5%6Positive News3.17%CORTCorcept Therapeutics$63.54-2.4%4.7297 of 5 stars3.00$88.25 38.9%5Upcoming Earnings2.90%JAZZJazz Pharmaceuticals$136.01-0.5%4.9569 of 5 stars2.93$180.33 32.6%15Upcoming EarningsNews Coverage2.82%LLYEli Lilly and Company$874.12+0.1%4.8446 of 5 stars2.85$1,007.94 15.3%20Positive News2.79%JNJJohnson & Johnson$162.35+1.7%4.5432 of 5 stars2.56$170.67 5.1%18Ex-DividendAnalyst ForecastOptions VolumePositive News2.66%PFEPfizer$26.32+1.6%4.9993 of 5 stars2.50$31.92 21.3%16Options VolumePositive News2.52%OGNOrganon & Co.$15.47-1.4%4.9284 of 5 stars2.43$20.80 34.5%72.51%BMYBristol-Myers Squibb$55.85+0.1%4.5925 of 5 stars2.30$57.86 3.6%20Analyst RevisionPositive News2.46%TARSTarsus Pharmaceuticals$47.84-1.8%1.1673 of 5 stars3.00$56.00 17.1%7Gap Up2.35%PRGOPerrigo$25.37+0.5%4.9672 of 5 stars2.40$35.00 38.0%5Dividend IncreaseAnalyst DowngradeNews Coverage2.32%EWTXEdgewise Therapeutics$27.07-0.1%1.6533 of 5 stars2.86$41.29 52.5%72.32%ELANElanco Animal Health$11.02-1.0%4.051 of 5 stars2.25$16.00 45.2%8Analyst Forecast2.29%ZTSZoetis$160.39+1.9%4.8729 of 5 stars3.08$215.40 34.3%12Positive News2.22%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume2.22%VTRSViatris$11.25+1.7%2.0155 of 5 stars2.00$13.67 21.5%3News Coverage2.09%HRMYHarmony Biosciences$34.56-0.9%4.7184 of 5 stars3.00$53.67 55.3%9Analyst ForecastAnalyst RevisionNews Coverage1.98%PBHPrestige Consumer Healthcare$84.66-0.1%4.1695 of 5 stars2.60$92.60 9.4%5Positive News1.78%HROWHarrow$28.95-3.9%2.2885 of 5 stars3.00$61.50 112.4%41.59%ANIPANI Pharmaceuticals$57.94-2.9%4.3784 of 5 stars3.00$77.71 34.1%81.53%PCRXPacira BioSciences$25.16-2.3%2.9696 of 5 stars2.22$22.78 -9.5%91.51%COLLCollegium Pharmaceutical$29.13-2.1%3.9883 of 5 stars2.80$43.60 49.7%5News Coverage1.43%LQDALiquidia$16.11-2.4%2.0541 of 5 stars3.11$25.38 57.5%91.28%ARVNArvinas$17.77-3.3%3.0809 of 5 stars3.00$60.00 237.6%12Gap Up1.21%CRMDCorMedix$10.13-6.4%1.3225 of 5 stars3.00$15.67 54.7%6News Coverage1.19%AMPHAmphastar Pharmaceuticals$31.28-0.1%4.4394 of 5 stars2.25$50.33 60.9%41.13%EOLSEvolus$13.99-4.3%3.8638 of 5 stars3.00$23.67 69.2%41.12%LGNDLigand Pharmaceuticals$120.56-1.2%4.1424 of 5 stars3.00$147.00 21.9%6Positive News1.02%SUPNSupernus Pharmaceuticals$33.05-4.5%1.6129 of 5 stars2.33$36.00 8.9%3Analyst DowngradeNews Coverage1.00%WVEWave Life Sciences$11.13-1.8%4.3638 of 5 stars3.00$22.22 99.7%9Positive NewsGap Up0.92%INVAInnoviva$18.08+0.1%2.7143 of 5 stars3.001Analyst DowngradeNews CoveragePositive News0.90%AMRXAmneal Pharmaceuticals$7.83-0.5%3.7662 of 5 stars2.80$10.00 27.7%5Positive News0.82%OCULOcular Therapeutix$7.00-3.4%3.3993 of 5 stars2.83$17.00 142.9%60.57%ELVNEnliven Therapeutics$21.80+1.5%1.8062 of 5 stars3.20$38.25 75.5%5Gap Up0.57%MNMDMind Medicine (MindMed)$7.63-6.7%2.1419 of 5 stars3.23$26.33 245.1%13Gap Up0.55%ZVRAZevra Therapeutics$7.68-1.9%1.8488 of 5 stars3.25$21.57 180.9%80.52%EYPTEyePoint Pharmaceuticals$6.15-3.1%1.3645 of 5 stars3.00$26.63 332.9%9Positive News0.51%ESPREsperion Therapeutics$1.83-1.4%4.4382 of 5 stars2.50$6.75 269.9%6Gap Down0.51%XERSXeris Biopharma$3.75-5.5%3.7339 of 5 stars2.75$5.15 37.3%4News Coverage0.47%PHATPhathom Pharmaceuticals$5.67+2.3%2.1726 of 5 stars2.80$23.00 305.6%50.45%PAHCPhibro Animal Health$22.50-2.0%4.079 of 5 stars1.50$21.00 -6.7%4Analyst Revision0.41%NUVBNuvation Bio$2.21-2.9%2.0453 of 5 stars3.00$8.20 271.9%50.21%NMRANeumora Therapeutics$1.80+5.3%4.074 of 5 stars2.71$16.50 816.7%7News Coverage This page (NYSEARCA:PILL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PILL Stock Alerts